Nivolumab-Induced Subcutaneous Fat Necrosis: Another FDG-Avid Immune-Related Adverse Event

Keyphrases

• Definitive Diagnosis 50%
• Fat Biopsy 50%
• Fat Density 50%
• Fat Necrosis 100%
• FDG-avid 100%
• FDG-PET Scan 50%
• Hyperechoic 50%
• Hypermetabolic 50%
• Image-guided Biopsy 50%
• Immune-related Adverse Events 100%
• Lower Extremity 50%
• Malignancy 50%
• Metastatic Melanoma 50%
• Nivolumab 100%
• Nodule 50%
• Older Women 50%
• PET Scan 50%
• Progressive Disease 50%
• Recurrent Melanoma 50%
• Restaging 50%
• Subcutaneous Fat Necrosis 100%
• Thigh 50%
• Tumor 50%
• Ultrasound 50%

Medicine and Dentistry

• Biopsy Technique 50%
• Cancer 50%
• Fat Necrosis 100%
• Image Guided Biopsy 50%
• Immune-Related Adverse Events 100%
• Melanoma 50%
• Metastatic Melanoma 50%
• Neoplasm 50%
• Nivolumab 100%
• Positron Emission Tomography-Computed Tomography 100%
• Progressive Disease 50%
• Subcutaneous Fat Necrosis 100%
• Thigh 50%